Recently, higher levels of Gal-3 measured in 9851 ARIC Study participants free of PAD at baseline were significantly associated with an elevated risk of PAD and critical limb ischemia over 17.4 years of follow-up. The gene discussed is LGALS3; the disease is peripheral arterial disease.